Literature DB >> 14627789

Clinical practice. Prolactinoma.

Janet A Schlechte1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14627789     DOI： 10.1056/NEJMcp025334

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  46 in total

1.  Neuro-oncology in a nutshell.

Authors:  Joachim M Baehring
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

2.  Effect of dopaminergic drug treatment on surgical findings in prolactinomas.

Authors:  Maria Menucci; Alfredo Quiñones-Hinojosa; Peter Burger; Roberto Salvatori
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

3.  Medical and surgical management of microprolactinoma.

Authors:  William T Couldwell; Martin H Weiss
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

4.  Cognitive and perceptual disturbances in a young man.

Authors:  Janos Zahajszky; Davin K Quinn; Felicia A Smith; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 5.  Pediatric Pituitary Adenoma: Case Series, Review of the Literature, and a Skull Base Treatment Paradigm.

Authors:  Avital Perry; Christopher Salvatore Graffeo; Christopher Marcellino; Bruce E Pollock; Nicholas M Wetjen; Fredric B Meyer
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-24

6.  Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment.

Authors:  Pietro Scarone; Marco Losa; Pietro Mortini; Massimo Giovanelli
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

7.  Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender difference.

Authors:  Julie Kreutz; Laurent Vroonen; Francoise Cattin; Patrick Petrossians; Albert Thiry; Liliya Rostomyan; Luaba Tshibanda; Albert Beckers; Jean-François Bonneville
Journal:  Neuroradiology       Date:  2015-04-07       Impact factor: 2.804

8.  Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Authors:  Laurent Vroonen; Patrizio Lancellotti; Monica Tomé Garcia; Raluca Dulgheru; Matilde Rubio-Almanza; Ibrahima Maiga; Julien Magne; Patrick Petrossians; Renata Auriemma; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

Review 9.  Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review.

Authors:  Tomáš Česák; Pavel Poczos; Jaroslav Adamkov; Jiří Náhlovský; Petra Kašparová; Filip Gabalec; Petr Čelakovský; Ondrej Choutka
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

Review 10.  Managing prolactin-secreting adenomas during pregnancy.

Authors:  Syed Ali Imran; Ehud Ur; David B Clarke
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.